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Ehlers-Danlos syndrome (EDS, ORPHA98249) comprises a group of clinically and genetically heterogeneous
heritable connective tissue disorders, chiefly characterized by joint hypermobility and instability, skin texture
anomalies, and vascular and soft tissue fragility. As many tissues can be involved, the underlying molecular defect
can manifest itself in many organs and with varying degrees of severity, with widespread implications for
anesthesia and perioperative management. This review focuses on issues relevant for anesthesia for elective and
emergency surgery in EDS. We searched the literature for papers related to all EDS variants; at the moment most of
the published data deals with the vascular subtype and, to a lesser extent, classic and hypermobility EDS.
Knowledge is fragmented and consists mostly of case reports, small case series and expert opinion. Because EDS
patients commonly require surgery, we have summarized some recommendations for general, obstetrical and
regional anesthesia, as well as for hemostatic therapy.
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Ehlers-Danlos Syndrome (EDS, Orphanumber: ORPHA98249)
is an umbrella term for a growing number of heritable
connective tissue disorders, mainly featuring joint hyper-
mobility and instability, skin texture anomalies and vascu-
lar and internal organ fragility [1-3]. The overall incidence
is 1:10,000 to 1:25,000 with no ethnic predisposition [4],
resulting in a presumed number of at least 20,000-50,000
EDS patients in the Northern America. However, the real
frequency is probably underestimated due to the general
lack of awareness among the various disciplines of such a
protean condition, especially for the most atypical presen-
tations. Clinical manifestations range from extremely mild
phenotypes to life-threatening complications. The current
Villefranche nosology recognizes six major subtypes,
comprising classic (corresponding to EDS type I and II
of the “old” Berlin nosology), hypermobile (EDS type* Correspondence: wiesmann@med.uni-marburg.de
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article, unless otherwise stated.III), vascular (EDS type IV), kyphoscoliotic (type VIA),
arthrochalasia (types VIIA and VIIB) and dermatospar-
axis (type VIIC), most of which are linked to mutations
in one of the genes encoding for fibrillar collagen pro-
teins or enzymes involved in post-translational modifi-
cation of these proteins. Recently, several new EDS
variants have been defined clinically and genetically. In
addition, there has recently been suggested a possible
connection between hypermobile EDS and the joint hy-
permobility syndrome [5], a relatively neglected rheuma-
tologic condition recognized by specific diagnostic criteria
[6]. However, not all researchers and clinicians agree
with this view, which may be clarified by future mo-
lecular studies [7].
For the purposes of this review, we will use the last
Villefranche classification. Most EDS subtypes are trans-
mitted as autosomal-dominant or recessive traits; a gen-
eral overview is presented in Table 1. For a comprehensive
overview of genetic and clinical features, there are several
published reviews on EDS [2,7]. Surgery is a concern [8].
Vascular EDS and the other rarer EDS variants with in-
creased vascular fragility, e.g. classic-like EDS with arterialtral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
Table 1 Overview on EDS variants, relevant criteria and genetic background
Common variant Major criteria Minor criteria Inheritance Causative gene(s)
Classic Skin hyperextensibility Smooth, velvety skin AD COL5A1, COL5A2
Widened atrophic scars Molluscoid pseudotumors
Joint hypermobility Subcutaneous spheroids
Complications of joint hypermobility
Muscle hypotonia, motor delay
Easy bruising
Manifestations of tissue extensibility and
fragility
Surgical complications
Positive family history
Hypermobility Hyperextensible and/or Recurring joint dislocations AD (?) Unknown
smooth, velvety skin Chronic joint/limb pain (single reports with mutations
in TNXB and COL3A1)
Generalized joint hypermobility Positive family history
Vascular Thin, translucent skin Acrogeria AD COL3A1
Arterial/intestinal/uterine fragility or
rupture
Hypermobility of small joints
Extensive bruising Tendon and muscle rupture
Characteristic facial appearance Talipes equinovarus
Early-onset varicose veins
Arteriovenous, carotid-cavernous sinus
fistula
Pneumothorax/pneumohemothorax
Gingival recessions
Positive family history, sudden death
in a close relative
Kyphoscoliotic Generalized joint hypermobility Tissue fragility, including atrophic scars AR PLOD1
Congenital hypotonia Easy bruising
Congenital and progressive scoliosis Arterial rupture
Scleral fragility and rupture of the
ocular globe
Marfanoid habitus
Microcornea
Osteopenia/porosis
Positive family history
Arthrochalasis Generalized joint hypermobility with
recurrent subluxations
Skin hyperextensibility AD COL1A1, COL1A2 (recurrent
mutations)
Congenital bilateral hip dislocation Tissue fragility, including atrophic
scars
Easy bruising
Hypotonia
Kyphoscoliosis
Osteopenia/porosis
Dermatosparaxis Severe skin fragility Soft, doughy skin texture AR ADAMTS2
Sagging, redundant skin Easy bruising
Premature rupture of fetal membranes
Large hernias (umbilical, inguinal)
Abbreviations: EDS Ehlers Danlos Syndrome, AD autosomal dominat, AR autosomal recessive.
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collagen [9] and kyphoscoliotic EDS are associated with
an increased frequency of arterial aneurysms and dissec-
tions. Vascular EDS is associated with spontaneous vis-
ceral ruptures. Due to the involvement of peri-articular
non-ossified connective tissue, many EDS subtypes, espe-
cially the hypermobile and arthrochalasis types, may pre-
dispose to the need for orthopedic surgery.
Methods
A literature search was conducted in PubMed and
EMBASE for all published literature on the clinical man-
agement of EDS. The searches, performed in November
2013, spanned the literature from 1950 to 2013. The fol-
lowing search string was used: Ehlers-Danlos [OR] EDS
[AND] anesthesia [OR] anaesthesia [OR] perioperative
management. A supplementary search was performed
using the references of the selected papers, as well as
from personal literature databases (TW, MC and FM).
The retrieved literature was screened for information
on anesthetic and perioperative management. Inter-
ventional studies (experimental or quasi-experimental
designs) were defined as those in which an investigator
determined the treatment regimen. Observational studies
were defined as those in which treatment was decided on
the basis of the clinical characteristics of each individual
patient. Studies were labeled as case reports or case series
when patients were individually described.
This review article does not include data obtained in
clinical or laboratory animal studies. Thus, no ethical ap-
proval by clinical ethical committees or governmental
responsibilities was needed for this article.
Results
A Pubmed search retrieved 102 articles, and EMBASE
72 articles. Three further articles were obtained from the
personal databases of the authors. There was one clinical
trial [10], the rest were case reports (one or more pa-
tients undergoing anesthesia for surgical or obstetrical
purposes), retrospective case series or reviews, guideline
recommendations or expert opinion. Most case reports
and case series deal with vascular EDS, a systematic pub-
lication bias towards the relatively rare vascular subtype
(EDS subtype IV) (5% of all EDS patients). Furthermore,
most retrieved case reports focus on peripartal manage-
ment (i.e. obstetrical anesthesia). Five retrieved papers
offered guidelines for EDS, dealing in part with anaes-
thetic [11], perioperative [12-14] or peripartal [15]
topics. Dolan et al. [16] published the first recommenda-
tions for anesthesia in EDS, and Kuczkowski [15] published
guidelines for obstetric anesthesia. Castori [14] summa-
rized the relevant aspects for surgery and anesthesia in pa-
tients with hypermobile EDS. A guideline by Orphanet
UK [12] focuses on emergencies in vascular EDS.Finally, the authors of this review published a comprehen-
sive peer-reviewed guideline in 2013 at the web-based
project “OrphanAnesthesia” (funded by the DGAI, the
German society of anesthesiology and Intensive Care
medicine) dealing with anesthesia and perioperative issues
in patients with EDS of all subtypes.
Discussion
Literature search did not identify any data with high
level of evidence concerning anesthetic issues of EDS; it
is mostly single case reports, case series, narrative re-
views and expert opinion. We decided to present the
published information and discuss its implications, based
clinical heuristics, for providing general, regional and
local anesthesia and perioperative care. Recommenda-
tions for surgical emergency management, obstetrical
care and delivery are published elsewhere [8,9,17]. Main
issues regarding perioperative management in patients
with EDS are presented in Table 2 and are discussed in
the following section.
Classic EDS commonly presents with various degrees
of skin fragility and hyperextensibility, defective wound
healing, easy bruising and generalized joint hypermobil-
ity. Hypermobile EDS is also characterized by minor but
often-recognizable skin anomalies and chronic musculo-
skeletal pain. Vascular EDS features thin, easily bruised,
translucent skin, with very marked fragility of blood ves-
sels. The gastro-intestinal tract and gravid uterus, and,
less commonly, lungs, spleen and liver, are prone to
spontaneous rupture. The natural history and pheno-
typic spectrum of the other three major variants and all
the emerging ones are less well known, but most share
tissue fragility and its complications with the more
common subtypes. Therefore, carrying out a detailed
interview and clinical examination as well as contact-
ing the local/regional reference center is essential in
order to estimate the individual anesthetic/procedural
risks for each patient. Subtype classification, with par-
ticular attention to those variants with increased vascular
fragility (especially vascular EDS), should be obtained
before surgery.
Preoperative history and physical examination
Preoperative history and physical examination, general
assessment and subtype classification, results of previous
clinical genetic counseling, and a standardized bleeding
history [1,13,14] should be taken, as well as assessment
of any intubation difficulties. It is helpful to contact the
EDS specialist in charge to discuss open questions re-
garding the specific patient. Skin fragility, with regard to
shear forces or use of medical tapes, should be noted.
Laboratory results are usually within normal range and
mostly not helpful for estimating the bleeding risk. If
neuraxial anesthesia is contemplated, scoliosis, previous
Table 2 Anaesthestic preparations for patients with EDS
Patient history Check for the specific EDS subtype
Perform thorough bleeding anamnesis
Patient history with focus on EDS complications
Check for airway difficulties
Inform patient Inform the patient about relevant Issues of the underlying disorder with regard to planned anaesthesia
Discuss specific anaesthetic risks for general anaesthesia; discuss regional anaesthesia options with regard
to the underlying subtype
Discuss with surgeon Discuss the severity of the respective EDS in each specific patient
Has your local centre the appropriate facilities and experience for the planned
operation AND the underlying EDS?
Strategies for bleeding therapy in vascular EDS subtypes
Avoidance of tourniquets, adequate patient positioning
Avoid ambulatory surgery
Early mobilization strategy
Organize Cross match blood products, preparation of autotransfusion devices
Difficult airway management (performed by an expert with adequate devices)
Prolonged postoperative care facilities
Inform preoperatively Inform all team members including PACU and ward nurses in advance for optimal patient care
Be aware Typical EDS-related emergency-like situations such as difficult airway status, bleeding risks and organ
rupture in specific subtypes
Bleeding prophylaxis Use desmopressin in patients with positive bleeding history
Inform postoperatively Inform the patient of any anaesthetic difficulties. Fill out a detailed anaesthesia
problem card or medical report to anticipate difficulties in the future.
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out. Ineffectiveness of local anesthetics, e.g. during den-
tal procedures in the past, or block failure in previous at-
tempts of local or regional anesthesia should be noted.
Muscular weakness and signs of aortic or mitral insuffi-
ciency should be sought. A Doppler ultrasound scan might
help exclude subclinical cardiac pathology (e.g. non-
progressive aortic root dilatation or hemodynamically rele-
vant valve insufficiency).
A key factor is, that patients with EDS are treated in
the appropriate facility. Even small, elective surgery
might warrant referral to a specialized facility. Medical
teams unfamiliar with the specific risks and medical
needs of patients with EDS might have a severe impact
on morbidity and mortality in this specific population.Patient monitoring
Non-invasive monitoring should be performed whenever
possible, although some patients are prone to bruising
and hematoma formation by repetitive non-invasive
blood pressure measurements. On the other hand, inva-
sive blood pressure monitoring runs the risk of vascular
wall dissection (mainly for EDS subtypes with vascular
fragility); we recommend avoiding invasive measure-
ments whenever possible in non-emergency surgery invascular EDS. Ultrasound might reduce the risk of re-
peated vascular puncture.Patient positioning
Padding should be used to reduce shear forces and ex-
ternal tissue pressure. The eye should be protected as
direct force to the eyeball increases the risk of retinal de-
tachment and globe rupture, especially in kyphoscoliotic
EDS and brittle cornea syndromes with increased ocular
fragility, and in pathological myopia. One of the authors
(TW) has anecdotal knowledge of an iatrogenic retinal
detachment by a surgeon’s elbow in a patient during sur-
gery on the contralateral eye. A case report describes a
severe stretch injury to the brachial plexus [18] due to
intraoperative hyper abduction. Adhesive tapes and
wound dressing for fixation of devices should be easily
removable or avoided if possible because of the risk of
severe skin damage; the history should specifically ad-
dress this issue. This issue is of outstanding importance
in EDS with fragile skin such as dermatosparaxis and
other subtypes with fragile skin. Patient handling must
be performed with maximal reduction of shear forces of
the skin as even minor shear forces might result in se-
vere decollement injuries in these patient subgroups.
Pre- and postoperative written documentation of the
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gard to medicolegal issues in operations with need for
extreme patient positioning.
Airway management & ventilator strategies
In general, mask ventilation, intubation and laryngeal
mask insertion are all possible, but care is required with
mask ventilation to avoid temporomandibular joint lux-
ation. Repeated intubation attempts may cause bleeding;
smaller endotracheal tubes may reduce mucosal damage.
Cuff pressure should be checked frequently and kept as
low as possible. Airway pressure should be minimised
due to the risk of pneumothorax.
Difficult airway management and intubation may occur
in many forms of EDS with temporomandibular dysfunc-
tion, premature spondylosis, or occipitalatlantoaxial in-
stability [19] and should be anticipated with a higher
incidence than in general population. This might result in
high risk for accidental joint dislocation during intubation
attempts or in reduced joint mobility caused by spondyl-
osis resulting in reduced mouth opening. Subclinical cer-
vical spine instability may be present in patients with
preserved neck flexibility and temporomandibular joint
mobility or occipitoatlantooccipital instability. Care taken
here might prevent post-operative complications, such as
neck pain and compression-related neurological symp-
toms. Elective fibreoptic intubation should be considered
when difficulties are anticipated.
Laparoscopic surgery might result in higher inspiratory
positive pressure to achieve normocapnea during peritoneal
inflation. This might result in higher risk for pneumothorax.
Peritoneal CO2-inflation might theoretically result in cap-
nothorax. Postoperative chest X-ray or chest sonography
might be helpful to rule out this rare condition. More-
over, we recommend that the anesthetist should dis-
cuss the use of an open instead of an laparoscopic
approach in patients with vascular EDS subtypes with
regard to the bleeding risk and better hemostatic op-
tions in open approach surgery.
Circulatory issues
Postural orthostatic tachycardia syndrome (POTS) is some-
times a feature in EDS, especially those with the hyper-
mobile variant (or joint hypermobility syndrome) [20].
Preoperative infusion of crystalloid and early use of va-
sopressors may be helpful [14]. The effects of POTS
on perioperative care aren’t yet known; adequate post-
operative patient monitoring is recommended.
Crossmatching, bleeding prophylaxis and
thromboprophylaxis
Crossmatching adequate amounts of RBCs is advised for
patients at risk of bleeding (EDS subtypes with increased
vascular fragility, as well as patients with unknown orpositive bleeding history). In elective surgery, autologous
donation should be discussed. Cell-saving might be ad-
visable for major surgery [11]. For details we refer to the
review by Castori et al. [14]. Although laboratory testing
usually shows normal values for INR, PTT and other in-
vitro-tests (such as thrombelastometry, e.g. ROTEM™),
platelet aggregation abnormalities can be expected in
about 26% of patients [21]. New measures of platelet
function such as PFA-100™ or Multiplate™ show normal
values and should not be used routinely. About 90% of
EDS patients (all subtypes) bruise easily. In some classic
and dermatosparaxis EDS, and EDS subtypes with in-
creased vascular fragility, patients are prone to severe
bleeding and hematoma formation. De Paepe and Malfait
[22] have given a detailed review of bleeding disorders in
EDS patients. In acute bleeding (especially in vascular
EDS), we recommend an early aggressive hemostatic ther-
apy as well as intraoperative coagulation tests (in labora-
tory as well as point-of care, e.g. ROTEM™). Desmopressin
(DDAVP) improves the bleeding time and reduces trans-
fusion requirements [23-26] although the exact mechan-
ism is unknown. It increases plasma levels of Factor VIII
and von-Willebrand-Factor (vWF). Some authors recom-
mend its use preoperatively in vascular EDS [8,11,27].
In children with EDS, Mast et al. [26] showed that des-
mopressin decreased the bleeding time to 5.95 ± 2.41
(mean ± SD) min, from 11.26 ± 4.39 min (P < 0,001). A
retrospective analysis of 41 surgical procedures in those
26 patients showed no bleeding complications when
DDAVP was used compared with 30% of complications
when DDAVP was not given preoperatively. As in other
bleeding disorders or major surgery, use of prophylactic
tranexamic acid before surgery should be contemplated
[28]. The use of recombinant FVIIa for patients with
massive hemorrhagia and coagulopathy featured in two
case reports [28,29].
To our knowledge, no recommendations for thrombo-
prophylaxis in patients with EDS are published. This topic
should be ruled out on a case-by-case decision with regard
to the surgical treatment, individual bleeding risks as well
as postoperative mobility in each specific patient.
Pharmacology
Ehlers-Danlos syndrome is not associated with abnormal-
ities of pharmacokinetics or pharmodynamics, but a detailed
history might reveal relevant concurrent disease. General
anesthesia can be performed as balanced anesthesia with
volatile anesthetics, nitrous oxide or as total intravenous
anesthesia (TIVA). Depolarizing (Succinylcholine) as well as
non-depolarizing agents are safe. As some EDS patients
present with muscular weakness, monitoring of neuro-
muscular blockade is advised before emergence of the
anesthesia. In immobilized patients, the avoidance of
depolarizing agents (succinylcholine) is advisable.
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The anesthetist must discuss the benefits and drawbacks
with the surgeon if tourniquet is contemplated by the
surgeon. There is a high risk of hematoma and compart-
ment syndromes, as well untreatable diffuse bleeding in
EDS subtypes with vascular fragility. Some of the present
authors have anecdotal knowledge of severe and lethal
complications due to the use of tourniquets in elective
minor extremity surgery of vascular EDS patients. Dif-
fuse bleeding after use of a tourniquet has resulted in
massive compartment bleeding and hemorrhagic shock.
Central venous catheterization
EDS patients with vascular fragility are at great risks of
vascular rupture [30,31]. We recommend the avoidance
of central venous access and arterial puncture whenever
possible in these subtypes. The use of ultrasound for
central venous catheterization is recommended [32,33].
If central lines are needed in EDS patients (high risk sur-
gery, emergencies), ultrasound guidance is mandatory,
including visualization of correct wire localization within
the blood vessel [34]. Use of dilatators should be re-
stricted as they might worsen vascular damage. Jugular
vein puncture is preferred to subclavian catheterization
with regard to complications such as pneumothorax and
bleeding in patients with vascular EDS.
Regional anesthesia & local anesthesia
There is no clear recommendation for either general or
regional/local anesthesia. The Emergency guideline for
vascular EDS by Orphanet UK [35] strictly recommends
avoiding neuraxial blockade, as does Abouleish [36] for
obstetrical anesthesia. Nevertheless, there are several
case reports and case series of successful spinal and epi-
dural anesthesia in patients with vascular EDS, as well as
other subtypes. This may be due to an underreporting
bias and should not be seen as a general carte blanche.
Large trials are needed to estimate a potentially in-
creased risk for perforation, nerve injury or hematoma
formation in patients with tissue fragility and increased
risk of bleeding. This topic should be discussed with the
patient with regard to the patient-specific risks (e.g. EDS
subtype, bleeding diathesis, spinal pathology, a past his-
tory of hematomas or spontaneous organ rupture) and
the potential benefits of a neuraxial blockade (early
mobilization, pain control, the wish for awareness at cae-
sarean delivery).
A greater rate of postdural puncture headache (PDPH)
after neuraxial blockade might be expected, due to tissue
fragility, but there are no relevant studies. PDPH can be
stopped by an peridural blood patch. Theoretically, this
option exists in EDS patients, too.
Moreover, EDS subtypes with tissue fragility are linked
to high incidence of spontaneous dural rupture andresulting headache comparable to PDPH. In these spe-
cific highly-symptomatic patients, a peridural blood
patch might be a minimal-invasive option and might be
discussed between neurologist, neurosurgeon and the
anesthetist (as most of the anesthetists have regularly ex-
perience in performing blood patches due to PDPH).
Neuraxial blockade is of course more complicated in
the presence of spinal pathology (scoliosis, kyphosis,
spinal stenosis etc.). In addition, isolated or multiple
Tarlov cysts ( cerebrospinal-fluid filled perineurial cysts)
as a sign of meningeal involvement is a feature of specific
EDS subtypes (i.e. classic, hypermobile and kyphoscolio-
tic). Most Tarlov cysts are located in the S1 to S4 region
of the spinal cord and therefore only a relative contra-
indication for the performance of a spinal anesthesia or
thoracal or lumbal epidural anesthesia. However, one of
the authors (MC, unpublished data) has observed thor-
acic Tarlov cysts in hypermobile EDS patients.
Thus, we recommend to avoid neuraxial blockades in
patients with vascular EDS based on the lack of clear
benefits and the potential risks compared with a planned
general anesthesia. Neuraxial blockades in other EDS
types are feasible. However, thorough discussion of po-
tential benefits and riscs with the team and the specific
patient should be performed. Pre-interventional ultra-
sound imaging (or use of MRI) might help to rule out
relevant spine pathology in some patients who are
scheduled for a neuraxial blockade.
As mentioned above, there are few case reports [37] of
peripheral regional anesthesia in EDS. Nevertheless, be-
cause of the frequency of difficult airway status in many
EDS subgroups, peripheral regional anesthesia could be
indicated in limb surgery. As in neuraxial blockade, thor-
ough history and examination is essential. Tissue scaring
can theoretically hamper the spread of local anesthetics.
Ultrasound guidance is recommended to reduce the inci-
dence of vascular puncture and obtain better deposition
local anesthetic spread. With regard to the bleeding risk,
we do not recommend the performance of peripheral
nerve blockades in patients with vascular EDS. Peripheral
nerve blocks in patients with other EDS subtypes can be
advised on a case-by-case shared-decision making policy.
Topical local anesthetics, e.g. EMLA™ (an eutectic
mixture of topical lidocaine and prilocaine), or local in-
filtration anesthesia might be ineffective [10,38], due to
tissue scarring, as shown by a clinical study [39] using
EMLA™ cream in EDS patients and healthy controls.
This may be important when using EMLA™ in children
to facilitate painless venous puncture.
Obstetrical anesthesia
There are case series and retrospective analysis [13,40] with
parturients for all types of delivery (vaginal, forceps, caesar-
ean section) and for all common types for anesthesia
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mal delivery method, as uterine rupture and delayed
wound healing may complicate both vaginal delivery and
caesarean section. Severe bleeding - especially for patients
with vascular fragility - must always be anticipated. Elective
caesarean section is best in patients at great risk for com-
plications. Crossmatching of sufficient amounts of RBCs,
use of autotranfusion systems and DDAVP as prophylaxis
should be discussed.
In hypermobile EDS, episiotomy is associated with to
pelvic prolapse [41] and should be avoided. Instead of
performing episiotomy for vaginal delivery, ceasarean
section may be preferred.
There is no general recommendation for the mode of de-
livery in specific EDS types, which is discussed in detail
elsewhere [15,41,42]. The benefits of neuraxial blockade
for obstetrical anaesthesia should be balanced against the
increased risks in specific EDS subtypes [43] as mentioned
above. Some authors favour general anaesthesia in patients
with bleeding risks such as in vascular EDS [12]. Neverthe-
less, we recommend to avoid neuraxial regional anesthesia
(spinal or peridural anesthesia techniques) in vascular EDS.
Use of patient-controlled i.v. remifentanil instead of
neuraxial blockade for vaginal delivery might be a prag-
matic approach in patients with high risk for neuraxial
complications. In some countries, use of inhalative 50%
nitrous oxide is a common alternative for labour analgesia.
However, as there is the risk of spontenaous pneumo-
thorax in some patients with EDS, this treatment option
should be used only on a case-by-case decision.
Postoperative care
Little has been written about this topic. Careful patient
positioning and mobilisation is advised to reduce the risk
of joint luxation as well as reduction of shear forces with
regard to the skin fragility. In all EDS subtypes, early
mobilization is a essential to prevent loss of strength in
the musculoskeletal and cardiovascular systems, particu-
larly in the hypermobile subtype. Patients should be
checked thoroughly for development of bleeding and he-
matomas at the operation site. Patients with POTS should
be monitored for signs of cardiovascular instabilitly in the
first postoperative hours. Adequate prophylaxis of postop-
erative nausea and vomiting (PONV) is recommended as
spontaneous eosophageal rupture has been reported as a
result of vomiting in vascular EDS [8].
Ambulatory anesthesia
All EDS patients should be operated in centres with the
relevant expertise and knowledge [11]. With suspected
or obvious vascular fragility, bleeding (including devel-
oping compartment syndromes etc.) should be antici-
pated. All patients, even after minor surgery, should be
monitored for at least 24h.Perioperative emergencies
All PACU and ward nurses should be aware of spe-
cific acute situations in EDS such as vascular dissec-
tion (e.g. aortic dissection, peripheral arteries & veins)
caused spontaneously or iatrogenic (especially during
angiographic interventions [8]). Compartment syndromes
can be caused by vascular puncture or rupture due to
pressure and shear forces and resulting bleeding. Unstop-
pable bleeding from the operation site or organ rupture
(vascular EDS) may occur. Risk of pneumo- (hemo-)
thorax must be anticipated during positive pressure venti-
lation as well as central venous access. Moreover, spontan-
eous rupture or rupture after trivial trauma to the bowel,
uterus, esophagus or vagina has been reported. This risk is
greater in the post-operative period, and may occur at
sites remote from the site of surgery. All team members
should be aware of these possibilities in the postoperative
period to avoid delayed diagnosis when unusual symptoms
occur. These events are unusual in patients other than
vascular EDS; in this condition, even elective vascular,
gastro-intestinal and other surgery should be avoided
whenever possible.
Possible anesthetic complications
Careless patient positioning might enhance the risk for
brachial plexus neuropathy or visual loss due to direct
pressure to the eye. Skin damage and hematoma forma-
tion may occur due to shear forces and insufficient pa-
tient padding. Patients with atlantooccipital instability
may present airway difficulties and there is a risk of tem-
poromandibular joint luxation during mask ventilation
or intubation [11]. Scoliosis and other forms of spinal
pathology might complicate intubation attempts. In vas-
cular EDS, spontaneous pneumothorax due to mechanical
ventilation and upper airway bleeding during repeated in-
tubation attempts may occur [12].
As reported above, there may be a predisposition to
postdural puncture headache (PDPH), or greater risk of
epidural hematoma. Both issues should be discussed
with the patient. Nevertheless, this advice comes from
expert opinion; there is also a case series of patients with
spontaneous CSF leaks with high rates of underlying
EDS [44]. Published literature of patients with neuraxial
blockade (mostly obstetrical anesthesia) shows only one
postdural puncture headache (PDPH), and that in a pa-
tient with vascular EDS [40]. Prospective studies are
needed for estimating the risk of PDPH and bleeding
complications in neuraxial blockades in EDS patients.
Conclusion
EDS is challenging for the anesthetist, and there is little
evidence-based knowledge.
Therefore, a registry for perioperative complications in
patients with EDS might help to improve safety for
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population. However, safe anesthesia can be provided
with adequate preparations and personal, organizational
and technical resources. The above recommendations
must be adequately crosschecked for each patient. The
authors recommend prospective acquisition of previous
anesthesia charts in any specific patient population to
make realistic risk estimation with regard to airway diffi-
culties, bleeding complications and neuraxial techniques
and complication rates.
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